G6PD deficiency in Latin America: Systematic review on prevalence and variants

Memorias do Instituto Oswaldo Cruz

Volumn 109, Issue 5, 2014, Pages 553-568

  Monteiro, Wuelton M ^a,b   Val, Fernando F A ^a,b   Siqueira, André M ^a,b   Franca, Gabriel P ^a   Sampaio, Vanderson S ^a,b   Melo, Gisely C ^a,b   Almeida, Anne C G ^a,b   Brito, Marcelo A M ^a,b   Peixoto, Henry M ^c   Fuller, Douglas ^d   Bassat, Quique ^e   Romero, Gustavo A S ^c,f   Oliveira, Maria Regina F ^c,f   Lacerda, Marcus Vinícius G ^a,b  

^a FUNDAÇÃO DE MEDICINA TROPICAL DR HEITOR VIEIRA DOURADO   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

^d UNIVERSITY OF MIAMI   (United States)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f Instituto Nacional de Ciencia e Tecnologia para Avaliacao de Tecnologias em Saude (IATS) CNPq   (Brazil)

Author keywords

Amerindians; G6PD deficiency; Haemolysis; Malaria control; Plasmodium vivax; Primaquine

Indexed keywords

ANTIMALARIAL AGENT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PRIMAQUINE;

CARIBBEAN; CONTRAINDICATIONS; DRUG EFFECTS; FEMALE; GENETICS; GEOGRAPHIC MAPPING; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; MALARIA, VIVAX; MALE; PREVALENCE; SOUTH AND CENTRAL AMERICA;

ANTIMALARIALS; CARIBBEAN REGION; FEMALE; GEOGRAPHIC MAPPING; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMANS; LATIN AMERICA; MALARIA, VIVAX; MALE; PREVALENCE; PRIMAQUINE;

EID: 84906731089     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276140123     Document Type: Article

References (147)

1. Agudelo-Flórez P, Costa-Carvalho BT, López JA, Redher J, Newburger PE, Olalla-Saad ST, Condino-Neto A 2004. Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections. Am J Hematol 75: 151-156.
2. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE 1960. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ 22: 621-631.
3. Arámbula E, Aguilar LJC, Vaca G 2000. Glucose-6-phosphate dehydrogenase mutations and haplotypes in Mexican Mestizos. Blood Cells Mol Dis 26: 387-394.
4. Arends T 1966. Haemoglobinopathies, thalassemia and glucose-6-phosphate deficiency in Latin America and the West Indies. NZ Med J 65: 831-844.
5. Azevêdo ES, Alves AF, da Silva MC, Souza MG, Lima AMMD, Azevedo WC 1980. Distribution of abnormal hemoglobins and glucose-6-phosphate dehydrogenase variants in 1,200 school children of Bahia, Brazil. Am J Phys Anthropol 53: 509-512.
6. Azevedo ES, Azevedo TFS 1974. Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Bahia, Brazil. Cienc Cult 26: 44-47.
7. Azevêdo ES, Silva KM, da Silva MC, Lima AM, Fortuna CM, Santos MG 1981. Genetic and anthropological studies in the island of Itaparica, Bahia, Brazil. Hum Hered 31: 353-357.
8. Azevedo ES, Yoshida A 1969. Brazilian variant of glucose 6-phosphate dehydrogenase (Gd Minas Gerais). Nature 222: 380-382.
9. Baird JK 2011. Radical cure: the case for anti-relapse therapy against all malarias. Clin Infect Dis 52: 621-623.
10. Baird JK, Surjadjaja C 2011. Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol 27: 11-16.
11. Baronciani L, Tricta F, Beutler E 1993. G6PD "Campinas": a deficient enzyme with a mutation at the far 3' end of the gene. Hum Mutat 2: 77-78.
12. Barretto OC 1983. New variant of erythrocyte glucose-6-phosphate dehydrogenase: Gd São Paulo. Rev Hosp Clin Fac Med Sao Paulo 38: 247-248.
13. Barretto OC, Nonoyama K 1987. Gd(+) Cuiabá, a new rare glucose-6-phosphate dehydrogenase variant presenting normal activity. Hum Genet 77: 201-202.
14. Barretto OC, Nonoyama K 1991. Gd(-) Carapicuiba, a rare glucose-6-phosphate dehydrogenase variant associated with moderate enzyme deficiency and chronic hemolysis. Braz J Med Biol Res 24: 133-139.
15. Best WR 1959. Absence of erythrocyte glucose-6-phosphate dehydrogenase deficiency in certain Peruvian Indians. J Lab Clin Med 54: 791.
16. Beutler E 1991. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 324: 169-174.
17. Beutler E 1994. G6PD deficiency. Blood 84: 3613-3636.
18. Beutler E, Duparc S 2007. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg 77: 779-789.
19. Beutler E, Kuhl W, Ramirez E, Lisker R 1991a. Some Mexican glucose-6-phosphate dehydrogenase variants revisited. Hum Genet 86: 371-374.
20. Beutler E, Kuhl W, Sáenz GF, Rodríguez W 1991b. Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica. Hum Genet 87: 462-464.
21. Beutler E, Westwood B, Prchal JT, Vaca G, Bartsocas CS, Baronciani L 1992. New glucose-6-phosphate dehydrogenase mutations from various ethnic groups. Blood 80: 255-256.
22. Bloch M, Sancho G, Rivera H 1970. Characteristics of GPD deficiency in El Salvador. Sangre (Barc) 15: 163-169.
23. Boada JJ, Yates AP 1979. Phenotypes of glucose-6 phosphate dehydrogenase in a Mestizo population. Acta Cient Venez 30: 172-174.
24. Bortolini MC, da Silva-Júnior WA, Weimer TA, Zago MA, de Guerra DC, Schneider MP, Layrisse Z, Castellano HM, Salzano FM 1998. Protein and hypervariable tandem repeat diversity in eight African-derived South American populations: inferred relationships do not coincide. Hum Biol 70: 443-461.
25. Bortolini MC, Weimer TA, Salzano FM, Moura LB, Silva MCBO 1997. Genetic structure of two Afro-Brazilian populations. Int J Anthropol 12: 5-16.
26. Cappellini MD, Fiorelli G 2008. Glucose-6-phosphate dehydrogenase deficiency. Lancet 371: 64-74.
27. Cardoso MA, Scopel KKG, Muniz PT, Villamor E, Ferreira MU 2012. Underlying factors associated with anemia in Amazonian children: a population-based, cross-sectional study. PLoS ONE 7: e36341.
28. Carmona-Fonseca J, Alvarez G, Maestre A 2009. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment. Am J Trop Med Hyg 80: 188-193.
29. Castro GA, Snyder LM 1974. G6PD San José: a new variant characterized by NADPH inhibition studies. Humangenetik 21: 361-363.
30. Castro SM, Weber R, Matte U, Giugliani R 2007. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in patients from the southern Brazilian city of Porto Alegre, R.S. Genet Mol Biol 30: 10-13.
31. Chadee DD, Tilluckdharry CC, Doon R 1996. Imported cerebral malaria complicated with glucose-6-phosphate dehydrogenase deficiency. West Indian Med J 45: 97-99.
32. Chaves M, Sáenz GF, Quintana E, Montero A, Jiménez J 1988. Polymorphism of erythrocytic glucose-6-phosphate dehydrogenase in Costa Rica. Sangre (Barc) 33: 12-14.
33. Clark TG, Fry AE, Auburn S, Campino S, Diakite M, Green A, Richardson A, Teo YY, Small K, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Sabeti P, Kwiatkowski DP, Rockett KA 2009. Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet 17: 1080-1085.
34. Compri MB, Saad ST, Ramalho AS 2000. Genetico-epidemiological and molecular investigation of G-6-PD deficiency in a Brazilian community. Cad Saude Publica 16: 335-342.
35. Conceição MM, Salzano FM, Franco MHLP, Weimer TA, Krieger H 1987. Demography, genetics and race admixture in Aracaju, Brazil. Rev Bras Genet 10: 313-331.
36. Cossio-Gurrola G, Arámbula-Meraz E, Perea M, García N, Correa AS, Rueda K, Chial M 2010. Glucose-6-phosphate dehydrogenase (G6PD) molecular variant deficiency: identification in Panama pediatric population. Blood Cells Mol Dis 44: 115-116.
37. Dal Borgo PA, Rosario SC, Cavieres AM 2000. Dos nuevas mutaciones de glucose-6-fosfato deshidrogenasa, G6PD Santiago y G6PD Calvo Mackenna. Rev Chil Pediatr 71: 419-422.
38. Das P, Horton R 2010. Malaria elimination: worthy, challenging and just possible. Lancet 376: 1515-1517.
39. de Gurrola GC, Araúz JJ, Durán E, Aguilar-Medina M, Ramos-Payán R, García-Magallanes N, Pacheco GV, Meraz EA 2008. Kernicterus by glucose-6-phosphate dehydrogenase deficiency: a case report and review of the literature. J Med Case Rep 2: 146.
40. del Cueto ME 2008. Caracterización molecular de variantes de glucosa-6-fostato deshidrogenasa (G6PD) en la población cubana. Rev Cubana Hematol Inmunol Hemoter 24: 1-9.
41. Dern RJ, Beutler E, Alving AS 1954. The hemolytic effect of primaquine. I.I. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med 44: 171-176.
42. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, Carter N, Cheng Q, Culpepper J, Eziefula C, Fukuda M, Green J, Hwang J, Lacerda M, McGray S, Menard D, Nosten F, Nuchprayoon I, Oo NN, Bualombai P, Pumpradit W, Qian K, Recht J, Roca A, Satimai W, Sovannaroth S, Vestergaard L, von Seidlein L 2013. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J 12: 391.
43. Douglas NM, John GK, Seidlein L, Anstey NM, Price RN 2012. Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malaria. Adv Parasitol 80: 271-300.
44. Elizondo J, Sáenz GF, Páez CA, Ramón M, García M, Gutiérrez A, Estrada M 1982. G6PD-Puerto Limón: a new deficient variant of glucose-6-phosphate dehydrogenase associated with congenital non-spherocytic hemolytic anemia. Hum Genet 62: 110-112.
45. Estrada M, García M, Gutiérrez A, Quintero I, González R 1982. G6PD Varadero. A new variant of glucose-6-phosphate dehydrogenase associated with congenital non-spherocytic hemolytic anemia. Vox Sang 43: 102-104.
46. Ferreira MES, Gomes MSM, Vieira JLF 2011. Methemoglobinemia in patients with Plasmodium vivax receiving oral therapy with primaquine. Rev Soc Bras Med Trop 44: 113-115.
47. Ferrell RE, Bertin T, Barton SA, Rothhammer F, Schull WJ 1980. The multinational Andean genetic and health program. I.X. Gene frequencies and rare variants of 20 serum proteins and erythrocyte enzymes in the Aymara of Chile. Am J Hum Genet 32: 92-102.
48. Fonseca D, Mateus H, Silva C, Contreras N, Restrepo C 2005. Deficiencia de glucosa-6-fosfato deshidrogenasa: aspectos generales de la eritroenzimopatía más frecuente en el mundo. Acta Med Colomb 30: 59-64.
49. Franco JL 1979. The slave trade in the Caribean and Latin America from the fifteenth to the nineteenth century. In United Nations Educational, Scientific and Cultural Organization (ed.), The African slave trade from the fifteenth to the nineteenth century, Imprimeries Réunies de Chambéry, Paris, p. 88-100.
50. Franco MH, Weimer TA, Salzano FM 1982. Blood polymorphisms and racial admixture in two Brazilian populations. Am J Phys Anthropol 58: 127-132.
51. Frank JE 2005. Diagnosis and management of G6PD deficiency. Am Fam Physician 72: 1277-1282.
52. Garlipp CR, Ramalho AS 1988. Aspectos clínicos e laboratoriais da deficiência de desidrogenase de 6-fosfato de glicose (G-6-PD) em recém-nascidos brasileiros. Rev Bras Genet 11: 717-728.
53. Geerdink RA, Bartstra HA, van Veen JMS 1974. Serum proteins and red cell enzymes in Trio and Wajana Indians from Surinam. Am J Hum Genet 26: 581-587.
54. Gibbs WN, Ottey F, Dyer H 1972. Distribution of glucose-6-phosphate dehydrogenase phenotypes in Jamaica. Am J Hum Genet 24: 18-23.
55. Gonzalez OL, Espina AL, Calcines PH 1990. G6P-DH Santa Clara and G6P-DH Villa Clara: two new Cuban variants. Acta Paediatr Hung 30: 17-26.
56. González R, Estrada M, Colombo B 1975. G-6-PD polymorphism and racial admixture in the Cuban population. Humangenetik 26: 75-78.
57. González R, Estrada M, García M, Gutierrez A 1980. G6PD Ciudad de la Habana: a new slow variant with deficiency found in a Cuban family. Hum Genet 55: 133-135.
58. González-González O, Calcines P 1986. Alteraciones metabolicas eritrocitarias en recién nacidos a término con ictericia fisiologica: glutation reducido y glucosa-6-fosfato deshidrogenasa. Medicentro 2: 89-93.
59. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IRF, Baird JK, Snow RW, Hay SI 2010. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 4: e774.
60. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA 2007. X-linked G6PD deficiency protects hemizygous males, but not heterozygous females against severe malaria. PLoS Med 4: e66.
61. Gutiérrez A, García M, Estrada M, Quintero I, González R 1987. Glucose-6-phosphate dehydrogenase (G6PD) Guantánamo and G6PD Caujerí: two new glucose-6-phosphate dehydrogenase-deficient variants found in Cuba. Biochem Genet 25: 231-238.
62. Haddix A, Teutsch SM, Corso PS 2003. Prevention effectiveness-a guide to decision analysis and economic evaluation, 2nd ed., Oxford University Press, Oxford, 264 pp.
63. Hamel AR, Cabral IR, Sales TSI, Costa FF, Saad STO 2002. Molecular heterogeneity of G6PD deficiency in an Amazonian population and description of four new variants. Blood Cells Mol Dis 28: 399-406.
64. Hidalgo PC, González OL, Rodríguez M, Castellanos T 1987. Análisis del polimorfismo genético de la G-6-PD eritrocitaria en la región central de Cuba. Rev Medicentro Electrónica 3: 149-157
65. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ 2006. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 75: 402-415.
66. Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, Sakuntabhai A, Satyagraha AW, Williams TN, Baird JK, Hay SI 2013. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J 12: 418.
67. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI 2012. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 9: e1001339.
68. Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, Cao J, Kachur SP, Feachem RGA, Gosling RD, Gao Q 2013. Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China. Malar J 12: 383.
69. Hutz MH, Yoshida A, Salzano FM 1977. Three rare G6PD variants from Porto Alegre, Brazil. Hum Genet 39: 191-197.
70. Iglessias MAC 2009. Frequência da deficiência de glicose-6-fosfato desidrogenase (G-6-PD) e sua relação com a icterícia neonatal. Rev Bras Hematol Hemoter 31: 57.
71. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, Nhem S, Bouchier C, Tichit M, Christophel E, Taylor WRJ, Baird JK, Menard D 2011. Performance of the CareStartTM G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE 6: e28357.
72. Kondrashin A, Baranova AM, Ashley EA, Recht J, White NJ, Sergiev VP 2014. Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Malar J 13: 51.
73. Lacerda MVG, Fragoso SCP, Alecrim MGC, Alexandre MAA, Magalhães BML, Siqueira AM, Ferreira LCL, Araújo JR, Mourão MPG, Ferrer M, Castillo P, Martin-Jaular L, Fernandez-Becerra C, Portillo H, Ordi J, Alonso PL, Bassat Q 2012a. Post-mortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis 55: 67-74.
74. Lacerda MVG, Mourão MPG, Alexandre MA, Siqueira AM, Magalhães BML, Martinez-Espinosa FE, Filho FSS, Brasil P, Ventura AMRS, Tada MS, Couto VSCD, Silva AR, Silva RSU, Alecrim MGC 2012b. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J 11: 12.
75. Leslie T, Briceño M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, Whitty CJM, Rowland M 2010. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS Med 7: e1000283.
76. Lisker R, Briceno RP, Agrilar L, Yoshida A 1978. A variant glucose-6-phosphate dehydrogenase Gd(-) Chiapas associated with moderate enzyme deficiency and occasional hemolytic anemia. Hum Genet 43: 81-84.
77. Lisker R, Briceño RP, Sosa R, Shein M 1976. Hereditary and epidemiological aspects of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Mexico. Gac Med Mex 111: 454-458.
78. Lisker R, Briceno RP, Zavala C, Navarrette JI, Wessels M, Yoshida A 1977. A glucose 6-phosphate dehydrogenase Gd (-) Castilla variant characterized by mild deficiency associated with drug-induced hemolytic anemia. J Lab Clin Med 90: 754-759.
79. Lisker R, Córdova MS, Zárate QBG 1969. Studies on several genetic hematological traits of the Mexican population. XVI. Hemoglobin S and glucose-6-phosphate dehydrogenase deficiency in the east coast. Am J Phys Anthropol 30: 349-354.
80. Lisker R, Linares C, Motulsky AG 1972. Glucose-6-phosphate dehydrogenase Mexico. A new variant with enzyme deficiency, abnormal mobility and absence of hemolysis. J Lab Clin Med 79: 788-793.
81. Lisker R, Pérez-Briceño R, Beutler E 1985. A new glucose-6-phosphate dehydrogenase variant, Gd(-) Tepic, characterized by moderate enzyme deficiency and mild episodes of hemolytic anemia. Hum Genet 69: 19-21.
82. Lisker R, Pérez-Briceno R, Granados J, Babinsky V 1988. Gene frequencies and admixture estimates in the state of Puebla, Mexico. Am J Phys Anthropol 76: 331-335.
83. Lisker R, Pérez-Briceño R, Ravé V, Yoshida A 1981. Federal District glucose-6-phosphate dehydrogenase Gd(-): a new variant associated with moderate enzyme deficiency and occasional hemolytic anemia. Rev Invest Clin 33: 209-211.
84. Lisker R, Ramirez E, Briceño RP, Granados J, Babinsky V 1990. Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol 62: 791-801.
85. Lisker R, Zarate G, Loria A 1966. Studies on several genetic hematologic traits of Mexicans I.X. Abnormal hemoglobins and erythrocytic glucose-6-phosphate dehydrogenase deficiency in several Indian tribes. Blood 27: 824-830.
86. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Möhrle JJ, Duparc S, Ugwuegbulam C, Kleim J-P, Carter N, Green JA, Kellam L 2013. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, Phase 2b dose-selection study. Lancet 383: 1049-1058.
87. Madrigal L, Sáenz G, Chávez M 1990. Glucose-6-phosphate dehydrogenase deficiency: its frequency in Hb AS and Hb AA individuals among the black population of Limón. Sangre (Barc) 35: 413-414.
88. malERA-Consultative Group on Basic Science and Enabling Technologies 2011. A research agenda for malaria eradication: basic science and enabling technologies. PLoS Med 8: e1000399.
89. Marques AC, Valencia A, Silva AR, Silva CJM, Fontes CJF, Netto JCA, Souza JM, Boulos M, Alecrim MGC, Tada MS, Tauil PL, Macedo VO, Alecrim WD 2001. Manual de terapêutica da malária. Available from: bvsms.saude.gov.br/bvs/publicacoes/funasa/manu_terapeutica_malaria.pdf.
90. Martínez-Labarga C, Rickards O, Scacchi R, Corbo RM, Biondi G, Peña JA, de Vieira CV, Guevara AE, Santurino MS, de Stefano GF 1999. Genetic population structure of two African-Ecuadorian communities of Esmeraldas. Am J Phys Anthropol 109: 159-174.
91. Mason PJ, Bautista JM, Gilsanz F 2007. G6PD deficiency: the genotype-phenotype association. Blood Rev 21: 267-283.
92. McCurdy PR, Maldonado N, Dillon DE, Conrad ME 1973. Variants of glucose-6-phosphate dehydrogenase (G-6-PD) associated with G-6-PD deficiency in Puerto Ricans. J Lab Clin Med 82: 432-437.
93. Medina MD, Vaca G, Esparza A, Westwood B, Beutler E 1995. Molecular heterogeneity of G-6-PD deficiency in Mexico. Arch Med Res 26: 111-113.
94. Medina MD, Vaca G, Lopez-Guido B, Westwood B, Beutler E 1997. Molecular genetics of glucose-6-phosphate dehydrogenase deficiency in Mexico. Blood Cells Mol Dis 23: 88-94.
95. Menéndez-Capote R, Pérez LD, Suárez CL 1997. Hemolysis and primaquine treatment. Preliminary report. Rev Cub Med Trop 49: 136-138.
96. Mezzacappa MA, Facchini FP, Pinto AC, Cassone AEL, Souza DS, Bezerra MAC, Albuquerque DM, Saad STO, Costa FF 2010. Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants. J Perinatol 30: 819-826.
97. Minucci A, Concolino P, Vendittelli F, Giardina B, Zuppi C, Capoluongo E 2008. Glucose-6-phosphate dehydrogenase Buenos Aires: a novel de novo missense mutation associated with severe enzyme deficiency. Clin Biochem 41: 742-745.
98. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E 2012. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis 48: 154-165.
99. Mockenhaupt FP, Mandelkow J, Till H, Ehrhardt S, Eggelte TA, Bienzle U 2003. Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency. Trop Med Int Health 8: 118-124.
100. Mohrenweiser H, Neel J 1984. A "disproportion" between the frequency of rare electromorphs and enzyme deficiency variants in Amerindians. Am J Hum Genet 36: 655-662.
101. Monsalve MV, Espinel A, de Restrepo HG, Calvo M, Suarez MC, Rodriguez A 1987. Frequency of five genetic polymorphisms in two populations of Colombia. Rev Bras Genet 10: 247-251.
102. Monteiro W, Franca G, Melo G, Queiroz A, Brito M, Peixoto H, Oliveira M, Romero G, Bassat Q, Lacerda M 2014. Clinical presentations of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes. Malar J 13: 70.
103. Moura-Neto JP, Dourado MV, Reis MG, Gonçalves MS 2008. A novel c.197T-> A variant among Brazilian neonates with glucose-6-phosphate dehydrogenase deficiency. Genet Mol Biol 31: 33-35.
104. Oliveira RAG, Oshiro M, Hirata MH, Hirata RDC, Ribeiro GS, Medeiros TMD, Barretto OCO 2009. A novel point mutation in a class IV glucose-6-phosphate dehydrogenase variant (G6PD São Paulo) and polymorphic G6PD variants in São Paulo state, Brazil. Genet Mol Biol 32: 251-254.
105. Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT 2010. Malaria in Brazil: an overview. Malar J 9: 115.
106. Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono AB, Luzzatto L 2012. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood 120: 4123-4133.
107. Pérez JLM, Meléndez PH 1989. Síndrome hemolítico por primaquina y deficiencia de glucosa-6-fosfato deshidrogenasa. Rev Cub Med Trop 41: 299-306.
108. Ramos-Júnior WM, Sardinha JFJ, Costa MRF, Santana MS, Alecrim MGC, Lacerda MVG 2010. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine in the Brazilian Amazon. Braz J Infect Dis 14: 410-412.
109. Ribeiro R, Cristina V, Santos C, Tavares F, Elias S 2012. Diretriz para análises de impacto orçamentário de tecnologias em saúde no Brasil. Cad Saude Publica 7: 1223-1238.
110. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peschu N 1995. Natural selection of hemi and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246-249.
111. Saad ST, Costa FF 1992. Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Brazil. Hum Hered 42: 125-128.
112. Saad ST, Costa FF 2003. Mild hemolysis in a girl with G6PD Sumaré (class I variant) associated with G6PD A-. Blood Cells Mol Dis 30: 238-240.
113. Saad ST, Costa FF, Salles TS, Sonatti MF, Figueiredo MS 1995. Glucose-6-phosphate dehydrogenase deficiency in sickle cell disease by DNA analysis. Blood 85: 601-602.
114. Saad ST, Salles TS, Arruda VR, Sonati MF, Costa FF 1997a. G6PD Sumaré: a novel mutation in the G6PD gene (1292 T-->G) associated with chronic non-spherocytic anemia. Hum Mutat 10: 245-247.
115. Saad ST, Salles TS, Carvalho MH, Costa FF 1997b. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Brazil. Hum Hered 47: 17-21.
116. Sáenz BR, Jiménez DM, Chaves VM, Quintana GEM, Sáenz RGF 1986. Coexistence of hemoglobin S and glucose-6-phosphate dehydrogenase deficiency in negroid population. Rev Costarric Cienc Med 7: 305-310.
117. Sáenz GF, Chaves M, Berrantes A, Elizondo J, Montero AG, Yoshida A 1984. A glucose-6-phosphate dehydrogenase variant, Gd(-) Santamaria found in Costa Rica. Acta Haematol 72: 37-40.
118. Sáenz GF, Chávez M, Briceño J, Quintana E, Arroyo G, Valenciano E, Porras AGM, Jiménez J 1985. Hemoglobin and erythrocyte G6PD polymorphism in preschool children in Santa Cruz, Guanacaste, Costa Rica. Rev Costarric Cienc Med 6: 126-130.
119. Saldanha PH, Nóbrega FG, Maia JC 1969. Distribution and heredity of erythrocyte G6PD activity and electrophoretic variants among different racial groups at São Paulo, Brazil. J Med Genet 6: 48-54.
120. Santana MS, Lacerda MVG, Barbosa MGV, Alecrim WD, Alecrim MGC 2009. Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in Manaus: a cross-sectional survey in the Brazilian Amazon. PLoS ONE 4: e5259.
121. Santana MS, Monteiro WM, Siqueira AM, Costa MF, Sampaio V, Lacerda MV, Alecrim MG 2013. Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon. Trans R Soc Trop Med Hyg 107: 301-306.
122. Santana MS, Rocha MAF, Arcanjo ARL, Sardinha JFJ, Alecrim WD, Alecrim MGC 2007. Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine. Rev Soc Bras Med Trop 40: 533-536.
123. Santos SEB, Guerreiro JF, Salzano FM, Weimer TA, Hutz MH, Franco MHLP 1987. Mobility, blood genetic traits and race mixture in the Amazonian population of Oriximiná. Rev Bras Genet 10: 745-759.
124. Schneider H, Guerreiro JF, dos Santos SEB, Weimer TA, Schneider MPC, Salzano FM 1987. Isolate breakdown in Amazonia: the blacks of the Trombetas River. Rev Bras Genet 10: 565-574.
125. Silva AR, Espinosa FEM, Souza JM, Boulos M, Alecrim MGC, Pereira MPL, Tada MS, Mascheretti M, Lapouble OMM, Marchesini P, Montoya RA, Braz RM, Chaves T, Alecrim WD 2010. Guia prático de tratamento da malária no Brasil. Available from: bvsms.saude.gov.br/bvs/publicacoes/guia_pratico_malaria.pdf.
126. Silva MCM, Santos EB, Costal EG, Filho MGS, Guerreiro JF, Póvoa MM 2004. Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day. Rev Soc Bras Med Trop 37: 215-217.
127. Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, Berman J 1999. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in non-immune Colombian soldiers. Clin Infect Dis 29: 199-201.
128. Steinhardt LC, Magill AJ, Arguin PM 2011. Review: malaria chemoprophylaxis for travelers to Latin America. Am J Trop Med Hyg 85: 1015-1024.
129. Thaeler Jr AD, Arnold J, Alving AS 1953. A clinical study of primaquine (S.N. 13,272) in the treatment of malaria among the Miskito Indians of Nicaragua. Am J Trop Med Hyg 2: 989-999.
130. Tinley KE, Loughlin AM, Jepson A, Barnett ED 2010. Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg 82: 210-214.
131. Vaca G, Arámbula E, Esparza A 2002. Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Mexico: overall results of a 7-year project. Blood Cells Mol Dis 28: 436-444.
132. Vaca G, Arámbula E, Monsalvo A, Medina C, Nuñez C, Sandoval L, López-Guido B 2003. Glucose-6-phosphate dehydrogenase (G-6-PD) mutations in Mexico: four new G-6-PD variants. Blood Cells Mol Dis 31: 112-120.
133. Vaca G, Ibarra B, Cruz DG, Medina C, Romero F, Cantú JM, Beutler E 1985. G-6-PD Jalisco and G-6-PD Morelia: two new Mexican variants. Hum Genet 71: 82-85.
134. Vaca G, Ibarra B, Romero F, Olivares N, Cantú JM, Beutler E 1982. G-6-PD Guadalajara. A new mutant associated with chronic non-spherocytic hemolytic anemia. Hum Genet 61: 175-176.
135. von Fricken ME, Weppelmann TA, Eaton WT, Masse R, Madsen VE, Rochars B, Okech BA 2014. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. Am J Trop Med Hyg 91: 77-80.
136. von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, Baird K, Moyes C, Howes R, Ménard D, Bancone G, Winasti-Satyahraha A, Vestergaard LS, Green J, Domingo G, Yeung S, Price R 2013. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J 12: 112.
137. Vulliamy TJ, D'Urso M, Battistuzzi G, Estrada M, Foulkes NS, Martini G, Calabro V, Poggi V, Giordano R, Town M 1988. Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci USA 85: 5171-5175.
138. Weimer TA, Salzano FM, Hutz MH 1981. Erythrocyte isozymes and hemoglobin types in a southern Brazilian population. J Hum Evol 10: 319-328.
139. Weimer TA, Salzano FM, Westwood B, Beutler E 1993. Molecular characterization of glucose-6-phosphate dehydrogenase variants from Brazil. Hum Biol 65: 41-47.
140. Weimer TA, Salzano FM, Westwood B, Beutler E 1998. G6PD variants in three South American ethnic groups: population distribution and description of two new mutations. Hum Hered 48: 92-96.
141. Weimer TA, Schüler L, Beutler E, Salzano FM 1984. Gd (+) Laguna, a new rare glucose-6-phosphate dehydrogenase variant from Brazil. Hum Genet 65: 402-404.
142. Weimer TA, Tavares Neto J, Franco MHLP, Hutz MH, Salzano FM, Kubo RR, Rosa RTD, Friedrisch JR, Prata A 1991. Genetic aspects of Schistosoma mansoni infection severity. Rev Bras Genet 14: 623-630.
143. White NJ 2008. The role of anti-malarial drugs in eliminating malaria. Malar J 7: S8.
144. WHO-World Health Organization 1989. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ 67: 601-611.
145. WHO-World Health Organization 2010. Guidelines for the treatment of malaria. Available from: who.int/malaria/publications/atoz/9789241547925/en/.
146. WHO-World Health Organization 2012a. World Malaria Report 2012. Available from: who.int/malaria/publications/world_malaria_report_2012/en/.
147. WHO-World Health Organization 2012b. The safety and effectivenes of single dose primaquine as a P. falciparum gametocyte. Available from: who.int/malaria/mpac/sep2012/primaquine_single_dose_pf_erg_meeting_report_aug2012.pdf.